Clinical-Microbiomics A/S — Credit Rating and Financial Key Figures
CVR number: 37230634
Fruebjergvej 3, 2100 København Ø
Income statement (kEUR)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 13 182.68 | 18 368.35 | 16 768.94 | 2 550.00 | 1 779.00 |
| Employee benefit expenses | -11 998.27 | -15 620.93 | -16 806.21 | -3 098.00 | -3 382.00 |
| Total depreciation | - 201.65 | -1 305.39 | -1 330.68 | - 202.00 | - 378.00 |
| EBIT | 982.76 | 1 442.03 | -1 367.95 | - 750.00 | -1 981.00 |
| Other financial income | 88.89 | 19.00 | 9.00 | ||
| Other financial expenses | - 833.45 | -1 090.70 | -1 181.97 | - 238.00 | - 115.00 |
| Pre-tax profit | 149.31 | 440.22 | -2 549.92 | - 969.00 | -2 087.00 |
| Income taxes | -42.34 | 229.08 | 826.95 | 42.00 | 136.00 |
| Net earnings | 106.98 | 669.29 | -1 722.97 | - 927.00 | -1 951.00 |
Assets (kEUR)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 3 790.95 | 854.00 | 1 369.00 | ||
| Intangible assets total | 3 790.95 | 854.00 | 1 369.00 | ||
| Land and waters | 5 021.15 | 3 851.11 | 360.00 | 152.00 | |
| Machinery and equipment | 452.86 | 260.07 | 588.21 | 75.00 | 63.00 |
| Tangible assets total | 452.86 | 5 281.22 | 4 439.32 | 435.00 | 215.00 |
| Holdings in group member companies | 10 913.00 | 83 186.00 | |||
| Other receivables | 161.70 | 340.16 | 340.16 | 61.00 | 66.00 |
| Investments total | 161.70 | 340.16 | 340.16 | 10 974.00 | 83 252.00 |
| Long term receivables total | |||||
| Raw materials and consumables | 336.19 | 82.00 | 351.00 | ||
| Inventories total | 336.19 | 82.00 | 351.00 | ||
| Current trade debtors | 6 623.41 | 3 938.50 | 5 907.64 | 619.00 | 1 816.00 |
| Current amounts owed by group member comp. | 359.00 | 565.00 | |||
| Prepayments and accrued income | 554.84 | 202.06 | 1 516.96 | 393.00 | 863.00 |
| Current other receivables | 56.40 | 50.67 | 312.21 | 136.00 | 258.00 |
| Current deferred tax assets | 124.83 | 386.24 | 1 002.13 | 64.00 | 137.00 |
| Short term receivables total | 7 359.48 | 4 577.47 | 8 738.94 | 1 571.00 | 3 639.00 |
| Other current investments | 3 984.00 | ||||
| Cash and bank deposits | 3 564.48 | 7 397.52 | 10 620.52 | 1 113.00 | 1 410.00 |
| Cash and cash equivalents | 3 564.48 | 7 397.52 | 10 620.52 | 5 097.00 | 1 410.00 |
| Balance sheet total (assets) | 11 538.52 | 17 596.36 | 28 266.08 | 19 013.00 | 90 236.00 |
Equity and liabilities (kEUR)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 704.30 | 704.30 | 704.30 | 140.00 | 271.00 |
| Other reserves | 2 956.94 | 667.00 | 1 069.00 | ||
| Retained earnings | -4 957.86 | -4 818.55 | 887.34 | 16 168.00 | 86 901.00 |
| Profit of the financial year | 106.98 | 669.29 | -1 722.97 | - 927.00 | -1 951.00 |
| Shareholders equity total | -4 146.58 | -3 444.96 | 2 825.61 | 16 048.00 | 86 290.00 |
| Non-current loans from credit institutions | 4 620.75 | 5 403.36 | 3 882.11 | 770.00 | 555.00 |
| Non-current leasing loans | 4 131.30 | 151.00 | |||
| Non-current other liabilities | 447.90 | 5 417.51 | 159.18 | ||
| Non-current deferred tax liabilities | 178.00 | 182.00 | |||
| Non-current liabilities total | 5 068.65 | 10 820.87 | 8 172.59 | 1 099.00 | 737.00 |
| Current loans from credit institutions | 1 080.00 | 1 725.21 | 2 675.90 | 575.00 | 399.00 |
| Current trade creditors | 3 524.49 | 660.58 | 5 862.45 | 887.00 | 2 389.00 |
| Other non-interest bearing current liabilities | 5 123.58 | 6 043.59 | 5 677.79 | 122.00 | 240.00 |
| Accruals and deferred income | 888.38 | 1 791.07 | 3 051.75 | 282.00 | 181.00 |
| Current liabilities total | 10 616.45 | 10 220.45 | 17 267.89 | 1 866.00 | 3 209.00 |
| Balance sheet total (liabilities) | 11 538.52 | 17 596.36 | 28 266.08 | 19 013.00 | 90 236.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.